STUNNING: USAID + THE BIG GRIFT
Looks like USAID supported college tuition for Anwar Aulaqi (Awlaki) who later became a high level al Qaeda terrorist.
Aulaqi falsely claimed he was born in Yemen to secure the financial help via the State Dept. when he was actually a US citizen, born in Las Cruces New Mexico.
Aulaqi would later develop close ties with several 9/11 hijackers and attain leadership status in AQ's Yemen affiliate.
Aulaqi was the godfather of the digital jihad that leveraged his writings and the web to radicalize Americans to AQ's cause.
Aulaqi became the first American targeted for death by the CIA. In 2011, he was killed in a US drone strike.
This 1997 Aulaqi mugshot is for soliciting prostitutes.
Good catch first flagged Feb. 2025 via
@browne_pamela@intelwire
Ik gebruikte AI om 35+ rapporten van gevestigde instituten over de staat van Nederland te analyseren.
Wat eruit kwam wil niemand horen.
Ik heb het toch opgeschreven ⬇️
@chrisklomp Beste Chris, ik mag je niet, dat is prima. (geef jij niet om) Ik hoop wel dat je weer beter wordt! Dit gun je niemand! sterkte ermee. Wat ik ook wel mee zou willen geven: https://t.co/hbJPRK0jEz (wellicht een optie om te overwegen?)
🚨 IVERMECTIN + FENBENDAZOLE: A Cancer Survivor’s Story
A 59-year-old man from Liverpool was diagnosed with Stage 4 prostate cancer that had already metastasized to his lungs and spine. His PSA level measured 79, indicating an advanced and aggressive disease. Facing limited options, he chose to explore an unconventional path alongside standard medical treatment.
He began taking Fenbendazole and Ivermectin — two antiparasitic drugs that have gained attention for their potential anticancer properties. His regimen reportedly included Fenbendazole (~1000 mg, three times per week) and Ivermectin (12 mg daily, roughly 0.2 mg/kg), while he continued to follow his doctor’s guidance and monitored his progress closely.
Within four months, his PSA level dropped from 79 to 0.32, and scans showed a reduction in lesions affecting his lungs and spine. Throughout this period, he reported minimal side effects and was able to maintain a normal daily routine.
While this case is remarkable, it remains an isolated anecdote rather than scientific proof. Other factors — such as concurrent treatments, diet, supplements, or natural variability — could have played a role. Still, stories like this highlight why researchers are investigating drug repurposing as a possible avenue in cancer therapy.
I recently came across a father of five children who is trying to build a business using his skills as a woodsmith.
He builds high-quality wooden swords.
@TheMiddleborne needs to sell 25 swords per month to cover his family expenses and turn a profit. He has been struggling to do this and could use some help.
I purchased the two swords pictured below this morning.
If you feel inclined to help a small business owner support his family, check out the website here: https://t.co/zH0SbTmFdE